Mcneil Competitors and Similar CompaniesClear all
Mcneil's competitors and similar companies include Walvax Biotechnology, Shandong Saito Biotechnology, Biohaven Pharmaceutical and BPS Bioscience.
 Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. |  Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. |  BPS Bioscience BPS Bioscience is a company that designs and manufactures cell lines, recombinant proteins, and assay kits. | ||
Founding Date | Founding Date 1914 | Founding Date 2001 | Founding Date 2010 | Founding Date 2014 | Founding Date 2005 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations HQ Helsingborg, SE | Locations Kunming, CN HQ | Locations Heze, CN HQ | Locations New Haven, US HQ | Locations San Diego, US HQ |
Employees | Employees 1226% decrease | Employees 2,388 | Employees 95920% decrease | Employees 4343% increase | Employees 1012% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) 708.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) ¥961.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods ¥864.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit ¥140.3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income (¥84.7m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 72.8m | Total funding raised N/A | Total funding raised $ 80m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companyShandong Saito Biotechnology
HQ
Heze, CN
Employees
959↓ 20% decrease
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View companyBiohaven Pharmaceutical
HQ
New Haven, US
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View companyBPS Bioscience
HQ
San Diego, US
Employees
101↓ 2% decrease
BPS Bioscience is a company that designs and manufactures cell lines, recombinant proteins, and assay kits.
View company